CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | PHILLIPS BARCLAY A Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | Ossipow Vincent Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | Neermann Joerg Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | Vitt Daniel President and CEO | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | HOWSON TAMAR D Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-15 | van den Bossche Jan Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-06-03 | Vitt Daniel President and CEO | Purchase | +5,000 | $3.10 | $15K | 368,877 |
| 2022-06-03 | Whaley Glenn Chief Financial Officer | Purchase | +3,500 | $3.05 | $11K | 12,568 |
| 2022-05-12 | Muehler Andreas Chief Medical Officer | Purchase | +3,500 | $5.10 | $18K | 297,986 |
Page 9 of 9 · 170 trades